Pathstone Holdings, LLC Acumen Pharmaceuticals, Inc. Transaction History
Pathstone Holdings, LLC
- $25.3 Billion
- Q2 2025
A detailed history of Pathstone Holdings, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 1,058,531 shares of ABOS stock, worth $1.88 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,058,531
Previous 1,086,531
2.58%
Holding current value
$1.88 Million
Previous $1.2 Million
2.68%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ABOS
# of Institutions
72Shares Held
38.8MCall Options Held
31.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA14.9MShares$26.6 Million0.38% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$6.08 Million1.28% of portfolio
-
Franklin Resources Inc San Mateo, CA3.08MShares$5.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.84 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.95MShares$3.47 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $72.1M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...